| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 15.868 | 21.766 | 33.445 | 34.390 | 58.583 | 58.214 | 58.900 | 60.445 | 59.158 | 122.124 |
| Total Income - EUR | 15.868 | 21.768 | 37.386 | 34.390 | 58.584 | 58.214 | 58.900 | 60.445 | 59.158 | 122.124 |
| Total Expenses - EUR | 11.285 | 19.010 | 35.230 | 33.419 | 49.321 | 49.281 | 52.631 | 51.390 | 67.194 | 101.034 |
| Gross Profit/Loss - EUR | 4.583 | 2.758 | 2.156 | 972 | 9.263 | 8.933 | 6.269 | 9.055 | -8.036 | 21.091 |
| Net Profit/Loss - EUR | 4.107 | 2.540 | 1.782 | 628 | 8.677 | 8.351 | 5.680 | 8.450 | -8.594 | 18.875 |
| Employees | 4 | 4 | 4 | 2 | 2 | 2 | 2 | 3 | 3 | 4 |
Check the financial reports for the company - Valmedica-Medicină Complementară Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 4.002 | 3.961 | 0 | 263 | 14.541 | 16.496 | 6.882 | 3.895 | 8.604 | 19.137 |
| Current Assets | 3.587 | 5.306 | 9.096 | 7.901 | 8.622 | 6.966 | 11.739 | 15.780 | 49.968 | 72.969 |
| Inventories | 2.864 | 2.835 | 9.054 | 6.108 | 2.607 | 1.004 | 79 | 13.555 | 14.040 | 5.047 |
| Receivables | 180 | 2.171 | 0 | 0 | 0 | 0 | 0 | 944 | 83 | 211 |
| Cash | 543 | 300 | 42 | 1.793 | 6.015 | 5.962 | 11.660 | 1.281 | 35.845 | 67.710 |
| Shareholders Funds | -14.293 | -11.607 | 1.834 | 2.428 | 11.058 | 10.688 | 13.895 | 14.730 | 6.092 | 24.933 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 21.882 | 20.874 | 7.262 | 5.736 | 12.105 | 12.774 | 4.726 | 4.946 | 52.480 | 67.173 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8559 - 8559" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Valmedica-Medicină Complementară Srl